Skip to main content

Table 2 Patient characteristicsa

From: Overall survival among patients with activated phosphoinositide 3-kinase delta syndrome (APDS)

Characteristic

Patients (N = 351)

Sex, No. (%)

 

 Male

171 (49)

 Female

135 (38)

 Not reported

45 (13)

APDS type, No. (%)

 

 APDS1 (PIK3CD)

267 (76.1)

 APDS2 (PIK3R1)

83 (23.6)

 Not reported

1 (0.3)

Age at last follow-up

 

 Alive

 

   No. of patients with available data

310

   Mean (range), y

17.1 (0.5–67)

 Deceased

 

   No. of patients with available data

41

   Mean (range), y

19.6 (1–64)

  1. aBecause of rounding, percentages may not total 100%. APDS, activated phosphoinositide 3-kinase delta syndrome; PIK3CD, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta; PIK3R1, phosphoinositide-3-kinase regulatory subunit 1